PO.ET02.12 · 实验与分子治疗
Novel Therapeutics and Drug Targets 2
-
-
-
-
-
-
-
-
-
- 3082 3082 一种新型iNOS抑制剂作为炎性乳腺癌的靶向治疗策略 A novel iNOS inhibitor as a targeted therapeutic approach for inflammatory breast cancer Karina Ortega Martinez, Maria Florencia Chervo, Feng Li, Jenying Deng, Liliana Guzman-Rojas, Wei Qian, Jianying Zhou, Recep Bayraktar, Aireana Phillips, Ivonne Uzair, Mailin Li, Aijun Zhang, Spencer Hankins, Dale Hamilton, Zhonglin Liu, Christopher Lincoln, Christoforos Thomas, Jenny C. Chang
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 3097 3097 MBS309（一种 PD-1 靶向且 alpha 偏向的 IL-2）的临床前表征，展示出强效抗肿瘤活性和良好的安全性特征 Preclinical characterization of MBS309, a PD-1-targeted and alpha-biased IL-2, demonstrating robust anti-tumor activity and a favorable safety profile Jiangmei Li, Guangzhong Lin, Lunfeng Zhang, Shuo Huang, Shuang Qing, Feng Li, Mingze Sun, Hong Chen
-
-
